Florid xanthomatous pelvic lymph node reaction to metastatic prostatic adenocarcinoma: A sequela of preoperative androgen deprivation therapy

Archives of Pathology and Laboratory Medicine

Volumn 120, Issue 1, 1996, Pages 96-100

  Schned, Alan R ^a   Gormley, E Ann ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; FLUTAMIDE; LEUPRORELIN;

ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MALE; PELVIS LYMPH NODE; PREOPERATIVE TREATMENT; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; XANTHOMATOSIS;

ADENOCARCINOMA; ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FLUTAMIDE; HISTIOCYTES; HISTIOCYTOSIS; HUMANS; LEUPROLIDE; LYMPH NODES; LYMPHATIC DISEASES; LYMPHATIC METASTASIS; MALE; PELVIS; PROSTATECTOMY; PROSTATIC NEOPLASMS; XANTHOMATOSIS;

EID: 0030068423     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sebo TJ, Bostwick DG, Farrow GM, Eble JN. Prostatic xanthoma: a mimic of prostatic adenocarcinoma. Hum Pathol. 1994;25:386-389.
2. Civantos F, Soloway M. Inflammation and necrosis in prostatic carcinoma following presurgical luprolide and flutamide androgen inhibition. Mod Pathol. 1994;7:72A. Abstract.
3. Armas OA, Aprikian AG, Melamed J, et al. Clinical and pathobiological effects of neoadjuvant total androgen ablation therapy on clinically localized prostatic adenocarcinoma. Am J Surg Pathol. 1994;18:979-991.
4. Albores-Saavedra J, Vuitch F, Delgado R, Wiley E, Hagler H. Sinus histiocytosis of pelvic lymph nodes after hip replacement: a histiocytic proliferation induced by cobalt-chromium and titanium. Am J Surg Pathol. 1994;18:33-90.
5. Harris R, Schned A, Heaney J. Staging cancer of the prostate by endorectal MRI: lessons from a learning curve. Radiographics. 1995;15:813-829.
6. Schmid H-P, McNeal JE. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol. 1992;16:184-191.
7. Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, ed. Urologic Pathology: The Prostate. Philadelphia, Pa: Lea & Febiger; 1977:171-198.
8. Murphy WM, Soloway MS, Barrows GH. Pathologic changes associated with androgen deprivation therapy for prostate cancer. Cancer. 1991;68:821-828.
9. Têtu B, Srigley JR, Boivin J-C, et al. Effect of combination endocrine therapy (LHRH agonist and flutamide) on normal prostate and prostatic adenocarcinoma: a histopathologic and immunohistochemical study. Am J Surg Pathol. 1991;15: 111-120.
10. Van de Voorde, Elgamal AA, Van Poppel HP, et al. Morphologic and immunohistochemical changes in prostate cancer after preoperative hormonal therapy: a comparative study of radical prostatectomies. Cancer. 1994;74:3164-3175.
11. Armas OA, Melamed J, Aprikian A, et al. Effect of preoperative androgen deprivation therapy on prostatic carcinoma. Mod Pathol. 1993;6:55A. Abstract.
12. McCue PA, O'Hara BJ, Gomella LG, Rupp MJ. Histologic and morphometric analysis of total androgen blockade in stage C prostate carcinoma. Mod Pathol. 1993;6:63A. Abstract.
13. Vaillancourt L, Têtu B, Fradet Y, et al. Effect of neoadjuvant endocrine therapy (total androgen blockade) on normal prostate and prostatic carcinoma: a randomized study. Mod Pathol. 1994;7:85A. Abstract.
14. Srigley JR, Klotz L, Tenniswood M. Programmed cell death following neoadjuvant endocrine therapy in human prostate cancer. Mod Pathol. 1993;6: 70A. Abstract.
15. Braunstein H. Staining lipid in carcinoma of the prostate gland. Am J Clin Pathol. 1964;41:44-48.
16. Mao P, Nakao K, Angrist A. Human prostatic carcinoma: an electron microscope study. Cancer Res. 1966;26:955-973.
17. Brandes D, Kirchheim D. Histochemistry of the prostate. In: Tannenbaum M, ed. Urologic Pathology: The Prostate. Philadelphia, Pa: Lea & Febiger; 1977: 99-128.
18. Halliday K, Sillerud L, Hutson J, et al. Citrate/lipid values discriminate malignant from benign prostatic tissue. Mod Pathol. 1991;4:47A. Abstract.
19. Bjornsson BL, Cartwright J, Abrams J, et al. Post-prosthesis lymph node histiocytosis (PPLNH) mimicking hypernephroid type metastatic prostatic adenocarcinoma. Mod Pathol. 1994;7:70A. Abstract.
20. Kircher T. Silicone lymphadenopathy: a complication of silicone elastomer finger joint prostheses. Hum Pathol. 1980;11:240-244.
21. Groff GD, Schned AR, Taylor TH. Silicone-induced adenopathy eight years after metacarpophalangeal arthroplasty. Arthritis Rheum. 1981;24:1578-1581.
22. Soloway MS, Hachiya T, Civantos F, et al. Androgen deprivation prior to radical prostatectomy for T2b and T3 prostate cancer. Urology. 1994;43(suppl 2): 52-56.